Baseline patient characteristics
| Baseline patient characteristics | Placebo | Pancreatic enzyme therapy |
| Number of patients | 10 | 11 |
| Men/women | 4/6 | 4/7 |
| Age (y)1-150 | 79 (9) | 73 (11) |
| Weight loss (kg)1-150 | −12.9 (9.1) | −9.9 (5.7) |
| Body weight (kg)1-150 | 58.1 (8.1) | 59.0 (5.2) |
| Type of cancer (clinical diagnosis) | ||
| Pancreatic carcinoma | 9 | 10 |
| Distal common bile duct carcinoma | 1 | 0 |
| Ampullary carcinoma | 0 | 1 |
| Tumour size (cm)1-150 | 3.9 (1.0) | 3.5 (1.3) |
| Presence of liver metastases | 1 | 0 |
| Presence of lung metastases | 0 | 0 |
| Fat absorption coefficient1-150 | 72 (24) | 70 (28) |
| Karnofsky performance status1-150 | 78 (10) | 80 (11) |
| Diabetes mellitus | 3 | 2 |
↵1-150 Mean (SD).
For all items p>0.05.